BACK TO FUND'S DETAIL PAGE
All Holdings
All Holdings
692 Total Holdings:
As of 12/31/25
All Holdings:
1 -
15 of
692
| Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets 
|
|---|---|---|---|---|
| Capital Group Central Cash Fund | Short Term | 1,283,620 | $128,374,835.00 | 6.6% |
| U.S. Treasury 4.00% 11/15/2035 | Fixed Income | 85,340,000 | $84,179,905.00 | 4.33% |
| TREASURY NOTE 3.5% 12-31-30 | Fixed Income | 55,500,300 | $55,246,647.00 | 2.84% |
| U.S. Treasury 4.75% 8/15/2055 | Fixed Income | 42,811,000 | $42,181,969.00 | 2.17% |
| AbbVie, Inc. 5.05% 3/15/2034 | Fixed Income | 22,525,000 | $23,156,196.00 | 1.19% |
| U.S. Treasury 4.625% 11/15/2045 | Fixed Income | 23,543,000 | $23,035,356.00 | 1.18% |
| Morgan Stanley 4.356% 10/22/2031 (USD-SOFR + 1.074% on 10/22/2030) | Fixed Income | 17,010,000 | $16,957,796.00 | 0.87% |
| Boeing Co. (The) 2.75% 2/1/2026 | Fixed Income | 16,088,000 | $16,069,708.00 | 0.83% |
| Chubb INA Holdings, LLC 5.00% 3/15/2034 | Fixed Income | 15,727,000 | $16,094,650.00 | 0.83% |
| Morgan Stanley 4.892% 10/22/2036 (USD-SOFR + 1.314% on 10/22/2035) | Fixed Income | 16,365,000 | $16,226,372.00 | 0.83% |
| Takeda U.S. Financing, Inc. 5.20% 7/7/2035 | Fixed Income | 12,944,000 | $13,190,040.00 | 0.68% |
| Marsh & McLennan Cos., Inc. 5.00% 3/15/2035 | Fixed Income | 12,244,000 | $12,407,898.00 | 0.64% |
| Pfizer Investment Enterprises Pte., Ltd. 5.30% 5/19/2053 | Fixed Income | 12,914,000 | $12,236,532.00 | 0.63% |
| Boston Properties, LP 5.75% 1/15/2035 | Fixed Income | 11,634,000 | $11,971,735.00 | 0.62% |
| Bristol-Myers Squibb Co. 5.55% 2/22/2054 | Fixed Income | 11,973,000 | $11,766,621.00 | 0.6% |
All Holdings:
1 -
15 of
692